Insider Selling: Aspen Aerogels, Inc. (NYSE:ASPN) CAO Sells 2,000 Shares of Stock

Key Points

• Aspen Aerogels' CAO Santhosh P. Daniel sold 2,000 shares of stock for a total of $15,080, reducing his position by 10.06%.
• The company's stock is currently valued at $7.50, with a market cap of $617.70 million and a P/E ratio of -1.97.
• Despite a 33.8% revenue decline year-over-year, Aspen Aerogels reported better-than-expected earnings, with an EPS of ($0.04) compared to a consensus estimate of ($0.12).

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) CAO Santhosh P. Daniel sold 2,000 shares of Aspen Aerogels stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $7.54, for a total transaction of $15,080.00. Following the transaction, the chief accounting officer directly owned 17,879 shares in the company, valued at approximately $134,807.66. This trade represents a 10.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Aspen Aerogels Trading Up 0.5%

Shares of ASPN stock traded up $0.04 during trading hours on Monday, reaching $7.29. The company had a trading volume of 383,790 shares, compared to its average volume of 2,044,408. The firm has a market cap of $599.99 million, a price-to-earnings ratio of -1.91 and a beta of 2.73. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The company has a 50 day moving average of $6.86 and a 200 day moving average of $6.89.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The business had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%. Aspen Aerogels's quarterly revenue was down 33.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.21 earnings per share. On average, equities research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Institutional Trading of Aspen Aerogels

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Nisa Investment Advisors LLC increased its stake in shares of Aspen Aerogels by 1,094.8% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock valued at $28,000 after purchasing an additional 4,390 shares during the last quarter. SBI Securities Co. Ltd. increased its stake in shares of Aspen Aerogels by 67.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock valued at $38,000 after purchasing an additional 2,551 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Aspen Aerogels by 184.6% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company's stock valued at $43,000 after purchasing an additional 4,693 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of Aspen Aerogels in the 1st quarter valued at $43,000. Finally, Banque Cantonale Vaudoise bought a new position in shares of Aspen Aerogels in the 1st quarter valued at $45,000. Institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

ASPN has been the subject of several recent research reports. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Oppenheimer lowered Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Finally, Barclays downgraded shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their price target for the company from $7.00 to $16.00 in a report on Monday, August 11th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $19.50.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.